Cardiovascular surveillance of patients with severe Duchenne cardiomyopathy in neurological and respiratory rehabilitation. A case presentation

Rogelio Luis Romero Millares; Yolanda Rodríguez Gómez; Ricardo Amador García Hernández; Cilda Lorendis Sarduy Manzanares; Benny Rogelio Romero Rodríguez

2018, Number 1

<< Back Next >>

Rev Cub de Med Fis y Rehab 2018; 10 (1)

Cardiovascular surveillance of patients with severe Duchenne cardiomyopathy in neurological and respiratory rehabilitation. A case presentation

Romero MRL, Rodríguez GY, García HRA, Sarduy MCL, Romero RBR

Full text

How to cite this article

Language: Spanish
References: 11
Page: 134-141
PDF size: 316.86 Kb.

ABSTRACT

The Duchenne cardiomyopathy shows a high health improvement of several studies multicenters and multinationals through echocardiography investigation. The age stocking to develop cardiomyopathy is of 16,4 years. The purpose of the study was to present a case of this cardiomyopathytype in severe stadium that was rehabilitated neurologic andrespiratoryunder cardiovascular supervision that included electrocardiography for telemetry and Holter, as well as, reappraisal echocardiography. This patient is masculine, of 17 year-oldsand with 11 years’ survival. He has a severe myocardial affectation for echocardiography. Adverse cardiovascular events were not documented during the supervision of two rehabilitation cycles. We conclude that the patients with Duchenne cardiomyopathy can be rehabilitated, so much neurologic as respiratory in spite of being in advanced stadiums of the illness with heart affectation whenever they are supervised by personnel qualified in cardiovascular surveillance.

REFERENCES

Martínez Carrasco C, Villa Asensi JR, Luna Paredes MC, Osona Rodríguez de Torres FB, Pena Zarza JA, Larramona Carrera H, Costa Colomer J. Enfermedad neuromuscular: evaluación clínica y seguimiento desde la neumología. An Pediatr (Barc). 2014;81(4): 258.e1--58.e17.
Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidences study. Clin Pediatr, 2010;49(2):17–9.
McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, et al. Cardiac Issues in Duchenne Muscular Dystrophy. Circulation, 2015;131:1590-98.
Camacho Salas A. Distrofia muscular de Duchenne. An Pediatr Contin. 2014;12(2):47-54.
Jefferies JL, Eidem BW, Belmont JW,Craigen WJ,Ware SM,Fernbach SD, et al. Dilated cardiomyopathy in muscular dystrophy. Circulation, 2005;112:2799-804.
Spurney C, Shimizu R, Hache LP, Kolski H, Gordish-Dressman H, Clemens PR, et al. Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve, 2014;50(2):250–56.
Ronchetti MP, Slavsky A, Leal J, Díaz S, Alonso MB, Garrido J, et al. Descripción del caso presentado en el número anterior: Distrofia muscular de Duchenne. Arch Argent Pediatr, 2011;109(5):453-54.
Ministerio de Salud y Protección Social. Departamento Administrativo de Ciencia Tecnología e Innovación. Colciencias. Guía de práctica clínica para la detección temprana, atención integral, seguimiento y rehabilitación de pacientes con diagnóstico de distrofia muscular. 2015.
Kamdar F, Garry DJ. Dystrophin-deficient cardiomyopathy. JACC, 2016; 67(21):2533 – 46.
McNally EM, Kaltman JR, Woodrow Benson D, Canter CE, Cripe LH, Duan D, et al. Contemporary cardiacissues in Duchenne muscular dystrophy. Circulation, 2015;131:1590-1598.
Ha Jo W, YoungminEun L, Won Jung J, Young Choi J, Woong Gang S. Early marker of myocardial deformation in children with duchenne muscular dystrophy assessed using echocardiographic myocardial strain analysis. Yonsei Med J, 2016; 57(4):900-4 jul.